Block 1 Pharmacokinetics Flashcards
Pharmacokinetices domains
Absorption
Distribution
Metabolism (biotransformation)
Excretion
Enteral administration
GI tract: oral (PO), sublingual (SL), rectal (PR)
Pros & cons to enteral drug administration routes
PO: most convenient, safe, economical; variable absorption, irritation of GI, first-pass effect
SL: bypasses hepatic portal vein
PR: bypasses hepatic portal vein
Parenteral administration
Intravenous (IV), intramuscular (IM), subcutaneous (SC)
Pros & cons to parenteral drug admin routes
IV: immediate, emergency use, bypass GI, large volume; risk of adverse effects, training
IM: prompty, bypass GI, self-admin; limited volume, pain
SC: same as IM
Other routes of drug admin
Topical, transdermal (into systemic circulation), intra-arterial, intrathecal (into CNS), inhalation
Absorption of drugs
Lipid bilayer = polar/ionized harder to get across *Passive diffusion (depends on conc grad) Active transport (link transport proteins)
Transport proteins
Across epi -> intestine; OATP, p-glycoprotein (prevents absorption)
Ion trapping & gastric and plasma pH
Only non-ionized can pass lipid membranes
GI: 1.4
Plasma: 7.4
pKa of a drug
pH value at which ½ drug is ionized
Weak acid vs. weak base
WA: low pKa, diffusion at low pH, blocked at high pH
WB: high pKa, diffusion at high pH, blocked at low pH
Factors affecting oral absorption
Dosage formulations: enteric coating (dissolves at high pH), controlled release (for short T½)
Blood flow: poor absorption with shock, short bowel syndrome
GI motility: inc or dec contact time with drugs
First pass effect: metabolism by liver
Causes of inc and dec GI motility
Inc: diarrhea, laxative
Dec: diabetes, anticholinergic drugs
Bioavailability
F = fraction entering systemic circulation (100% for parenteral drugs)
Low oral F for drugs subject to first-pass effect
First-pass effect
Drugs absorbed from GI metabolized by liver before reaching systemic circulation, decreases F for oral drugs
Factors affecting drug distribution
Organ blood flow: fast to highly perfused organs (liver, kidney, heart, lungs) vs. slow to less perfused (skin, fat, bone)
Plasma protein binding: inactive if bound to e.g. albumin, varying affinities for plasma proteins
Lipid solubility: soluble = greater Vd, can pass BBB
Volume of distribution
Vd; indirectly measured by plasma concentration
Vd = amount in body/plasma conc
Useful for calculating loading dose, elimination rate, T½
Fluid volumes in L per kg: plasma, extracellular fluid, intracellular fluid, total body water
P: 0.04 L/kg
Ex (plasma, interstitial): 0.25 L/kg
In: 0.35 L/kg
TBW (ex + in): 0.6 L/kg
Calculating loading dose
Vd = dose/Cp (desired plasma conc) Dose = Vd x Cp x kg
Drug metabolism: phase 1 and 2 reactions
To activate or inactivate and make easily excreted compounds
1: add small polar group by redox or hydrolysis, makes polar and H2O soluble
2: form water soluble conjugates that is inactive & easily eliminated
Cytochrome P450
Bound to membrane, contains heme, absorb 450 nm light with CO exposure
Primarily in liver, also intestine, lung, brain, placenta
Responsible for most phase 1 reactions
Makes chol, steroids, PCs, detoxes
*Changes = most drug interactions
Pro drug
Needs to be metabolized to become active; if dependent on P450 in short supply or inhibited, little or no clinical effect
Pro drug examples
Hydrocodone -> hydromorphone
Tramadol (Ultram) -> metabolite
Enalapril -> enalaprilat for HTN
Vyvanse (lisdexamfetamine) -> dextroamphetamine
Excretion of drugs
Biliary: conjugated metabolites, large molecular weight compounds, ? reabsorbed by enterohepatic cycling
Renal: most parent/metabolite, filtration depends on protein binding, active secretion, passive reabsorption (ion, lipid)
Clearance
Volume of plasma from which drug is eliminated per unit time (L/hr or ml/min)
Elimination rate = Cl x Css (plasma conc at steady state)
Creatinine clearance
Estimate of renal function, constant rate by-product of muscle, decreased GFR = rise of Scr until new steady state reached; must know sex, age, IBW, Scr
CrClest = [(140-age) x IBW (kg)] / (scr x 72) * x 0.85 for women
Zero order elimination & examples
Constant elimination rate, nonlinear/capacity limited, clearance inversely proportional to drug conc; phenytoin (Dilantin), aspirin (high doses), ethanol
First order elimination
At normal doses, rate of elimination proportional to plasma drug concentration
Elimination rate constant (Ke)
Fraction of drug eliminated over set period of time
Ke = clearance of drug (L/hr) / volume distribution (L)
= slope of semi-log conc curve
Half life relation to Ke
T½ = ~0.7/Ke T½ = ~(0.7 x Vd)/Cl
Steady state relation to half life
Take ~5 half lives to reach steady state after starting drug without loading dose
*Also 5 to eliminate after last dose
Predicting serum concentration at any time
Cp = (Cp^0)(e^-Ke.t) Cp = plasma conc at time t Cp0 = initial plasma conc Ke = elim rate constant t = time